Molecular Oncology
Volume 4, Issue 2 , Pages 150-160, April 2010

Targeting of VEGF-dependent transendothelial migration of cancer cells by bevacizumab

  • Gerald W. Prager

      Affiliations

    • Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, A-1090 Vienna, Austria
    • Both the authors contributed equally to this work.
    • ,
  • Eva-Maria Lackner

      Affiliations

    • Department of Ophthalmology, Medical University Graz, A-8020 Vienna, Austria
    • Both the authors contributed equally to this work.
    • ,
  • Maria-Theresa Krauth

      Affiliations

    • Department of Medicine I, Clinical Division of Hematology and Hemostaseology, Medical University Vienna, A-1090 Vienna, Austria
    • ,
  • Matthias Unseld

      Affiliations

    • Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, A-1090 Vienna, Austria
    • Department of Vascular Biology and Thrombosis Research, Medical University of Vienna, A-1090 Vienna, Austria
    • ,
  • Marina Poettler

      Affiliations

    • Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, A-1090 Vienna, Austria
    • ,
  • Sylvia Laffer

      Affiliations

    • Ludwig Boltzmann, Cluster Oncology, A-1090 Vienna, Austria
    • ,
  • Sabine Cerny-Reiterer

      Affiliations

    • Department of Medicine I, Clinical Division of Hematology and Hemostaseology, Medical University Vienna, A-1090 Vienna, Austria
    • ,
  • Wolfgang Lamm

      Affiliations

    • Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, A-1090 Vienna, Austria
    • ,
  • Gabriela V. Kornek

      Affiliations

    • Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, A-1090 Vienna, Austria
    • ,
  • Bernd R. Binder

      Affiliations

    • Department of Vascular Biology and Thrombosis Research, Medical University of Vienna, A-1090 Vienna, Austria
    • ,
  • Christoph C. Zielinski

      Affiliations

    • Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, A-1090 Vienna, Austria
    • Ludwig Boltzmann, Cluster Oncology, A-1090 Vienna, Austria
    • ,
  • Peter Valent

      Affiliations

    • Department of Medicine I, Clinical Division of Hematology and Hemostaseology, Medical University Vienna, A-1090 Vienna, Austria
    • Ludwig Boltzmann, Cluster Oncology, A-1090 Vienna, Austria
    • Corresponding Author InformationCorresponding author. Department of Medicine I, Clinical Division of Hematology and Hemostaseology, Medical University Vienna, A-1090 Vienna, Austria. Tel.: +43 1 40400 6085; fax: +43 1 40400 4030.

Received 28 August 2009; received in revised form 29 December 2009; accepted 4 January 2010. published online 15 January 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1574-7891(10)00003-7

doi:10.1016/j.molonc.2010.01.002

Molecular Oncology
Volume 4, Issue 2 , Pages 150-160, April 2010

Article Tools

* Image Usage & Resolution